DK1272225T3 - Lipidbaserede systemer til målrettet levering af diagnostiske midler - Google Patents

Lipidbaserede systemer til målrettet levering af diagnostiske midler

Info

Publication number
DK1272225T3
DK1272225T3 DK01921263T DK01921263T DK1272225T3 DK 1272225 T3 DK1272225 T3 DK 1272225T3 DK 01921263 T DK01921263 T DK 01921263T DK 01921263 T DK01921263 T DK 01921263T DK 1272225 T3 DK1272225 T3 DK 1272225T3
Authority
DK
Denmark
Prior art keywords
lipid
diagnostic agents
based systems
targeted delivery
sub
Prior art date
Application number
DK01921263T
Other languages
Danish (da)
English (en)
Inventor
Kent Jorgensen
Charlotte Vermehren
Sven Frokjaer
Ole G Mouritsen
Jesper Davidsen
Original Assignee
Liplasome Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liplasome Pharma As filed Critical Liplasome Pharma As
Application granted granted Critical
Publication of DK1272225T3 publication Critical patent/DK1272225T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK01921263T 2000-04-12 2001-04-11 Lipidbaserede systemer til målrettet levering af diagnostiske midler DK1272225T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000616 2000-04-12
PCT/DK2001/000269 WO2001076644A2 (en) 2000-04-12 2001-04-11 Lipid-based systems for targeting diagnostic agents

Publications (1)

Publication Number Publication Date
DK1272225T3 true DK1272225T3 (da) 2006-12-27

Family

ID=8159422

Family Applications (3)

Application Number Title Priority Date Filing Date
DK01921262T DK1272161T3 (da) 2000-04-12 2001-04-11 Lipid-baserede system til afgivelse af lægemidler mod parasitiske infektioner
DK01921263T DK1272225T3 (da) 2000-04-12 2001-04-11 Lipidbaserede systemer til målrettet levering af diagnostiske midler
DK01921261T DK1272160T3 (da) 2000-04-12 2001-04-11 Lipidbaseret lægemiddelleveringssystem til topisk applikation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK01921262T DK1272161T3 (da) 2000-04-12 2001-04-11 Lipid-baserede system til afgivelse af lægemidler mod parasitiske infektioner

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK01921261T DK1272160T3 (da) 2000-04-12 2001-04-11 Lipidbaseret lægemiddelleveringssystem til topisk applikation

Country Status (11)

Country Link
US (4) US20030170297A1 (pt)
EP (3) EP1272160B1 (pt)
JP (3) JP2003530339A (pt)
AT (2) ATE382333T1 (pt)
AU (3) AU2001248302A1 (pt)
CY (2) CY1105792T1 (pt)
DE (3) DE60126072T2 (pt)
DK (3) DK1272161T3 (pt)
ES (3) ES2295149T3 (pt)
PT (3) PT1272160E (pt)
WO (3) WO2001076644A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020001614A1 (en) * 2000-02-10 2002-01-03 Kent Jorgensen Lipid-based drug delivery systems containing phospholipase A2 degradable lipid derivatives and the therapeutic uses thereof
WO2002085391A1 (es) * 2001-04-24 2002-10-31 Luis Alberto Costa Uso de una fosfolipasa a2 para la preparacion de composiciones farmaceuticas y/o cosmeticas para la prevencion y/o el tratamiento local y/o sistemico de enfermedades y/o procesos provocados por patogenos intra y extracelulares que expresen fosfolipidos de membrana
US20050123925A1 (en) * 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20050112065A1 (en) * 2003-07-09 2005-05-26 Drummond Daryl C. Remote detection of substance delivery to cells
US20050266066A1 (en) * 2003-10-20 2005-12-01 Nof Corporation Phospholipid membrane preparation
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
JPWO2005073718A1 (ja) * 2004-01-28 2008-01-10 株式会社Ｌｔｔバイオファーマ 胃粘膜に安全な化合物のスクリーニング方法
DE102004010387A1 (de) * 2004-03-03 2005-09-22 Siemens Ag Kontrastmittel für die Röntgen-Computertomographie
WO2006086992A2 (en) * 2005-02-18 2006-08-24 Liplasome Pharma A/S Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
EP1861072A2 (en) * 2005-03-14 2007-12-05 Massachusetts Institute Of Technology Nanocells for diagnosis and treatment of diseases and disorders
WO2007043057A2 (en) * 2005-10-11 2007-04-19 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
AU2006328957C1 (en) * 2005-12-23 2013-01-10 Jado Technologies Gmbh Means and methods for the treatment and prevention of allergic diseases
JP2011026294A (ja) * 2009-06-26 2011-02-10 Canon Inc 化合物
US8993715B2 (en) * 2009-07-06 2015-03-31 Canon Kabushiki Kaisha Labeled protein and method for obtaining the same
CN102770162B (zh) 2009-08-21 2016-09-28 靶向递送技术有限公司 囊泡制剂
DK177532B1 (en) 2009-09-17 2013-09-08 Bio Bedst Aps Medical use of sPLA2 hydrolysable liposomes
DK177529B1 (en) 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
WO2011102906A1 (en) * 2010-02-19 2011-08-25 Robert Shorr Imageable lipid-oil-water nanoemulsion delivery system
WO2011102904A1 (en) * 2010-02-19 2011-08-25 Robert Shorr Imageable lipid-oil-water nanoemulsion therapeutic delivery system
WO2011102905A1 (en) * 2010-02-19 2011-08-25 Robert Shorr Imageable lipid-oil-water nanoemulsion diagnostic delivery system
US20150306035A1 (en) * 2012-03-09 2015-10-29 Universidade Federal De Minas Gerais- Ufmg Pharmaceutical composition containing conventional liposomes and prolonged-circulation liposomes for the treatment of visceral leishmaniasis
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
WO2014047116A1 (en) * 2012-09-18 2014-03-27 Comfort Care For Animals Llc Encapsulating liposomes
ES2895910T3 (es) 2015-06-30 2022-02-23 Sequessome Tech Holdings Limited Composiciones multifásicas
CN109996809A (zh) 2016-11-14 2019-07-09 诺华股份有限公司 与促融合蛋白minion相关的组合物、方法和治疗用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714865B2 (ja) * 1986-10-28 1995-02-22 武田薬品工業株式会社 リポソ−ム製剤およびその製造法
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
FR2638639A1 (fr) * 1988-11-08 1990-05-11 Parincos Parfumerie Cosmet Int Composition et procede d'obtention de liposomes oligolamellaires en vue d'une application en cosmetologie et dermatologie topique
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
US4874794A (en) * 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment
JPH0370491A (ja) 1989-08-04 1991-03-26 Toshiba Corp 電動機制御装置
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5705187A (en) * 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
CA2067754C (en) * 1990-08-24 2002-06-04 Gregor Cevc Preparation for the application of agents in mini-droplets
US5723115A (en) * 1991-05-02 1998-03-03 W. Alton Jones Cell Science Center, Inc. Inhibition of adipose tissue development and obesity
US5484911A (en) * 1993-04-01 1996-01-16 Health Research, Inc. Nucleoside 5'-diphosphate conjugates of ether lipids
DE4408011C1 (de) 1994-03-10 1995-11-02 Max Delbrueck Centrum Pharmazeutisches Mittel zur Tumortherapie
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US5827836A (en) * 1996-11-15 1998-10-27 Clarion Pharmaceuticals Inc. Retinoid glycerol phospholipid conjugates
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6048736A (en) * 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
US6444640B1 (en) * 1999-09-30 2002-09-03 Ludwig Institute For Cancer Research Compositions of trail and DNA damaging drugs and uses thereof

Also Published As

Publication number Publication date
CY1106462T1 (el) 2012-01-25
WO2001076555A3 (en) 2002-03-14
WO2001076555A2 (en) 2001-10-18
CY1105792T1 (el) 2011-02-02
US20030175205A1 (en) 2003-09-18
DK1272160T3 (da) 2007-05-21
PT1272160E (pt) 2007-04-30
AU2001248303A1 (en) 2001-10-23
EP1272160A2 (en) 2003-01-08
ES2270991T3 (es) 2007-04-16
JP2003530362A (ja) 2003-10-14
DE60126072D1 (de) 2007-03-08
US20070134153A1 (en) 2007-06-14
ATE382333T1 (de) 2008-01-15
US7166297B2 (en) 2007-01-23
US7368254B2 (en) 2008-05-06
PT1272161E (pt) 2008-02-08
WO2001076556A2 (en) 2001-10-18
EP1272161A2 (en) 2003-01-08
US20030162748A1 (en) 2003-08-28
WO2001076644A3 (en) 2002-03-14
WO2001076644A2 (en) 2001-10-18
AU2001248301A1 (en) 2001-10-23
AU2001248302A1 (en) 2001-10-23
DE60132184D1 (de) 2008-02-14
DE60122304T2 (de) 2007-08-09
ATE336267T1 (de) 2006-09-15
JP2003530339A (ja) 2003-10-14
WO2001076556A3 (en) 2002-07-11
DE60126072T2 (de) 2007-11-08
PT1272225E (pt) 2007-01-31
JP2003530338A (ja) 2003-10-14
US20030170297A1 (en) 2003-09-11
EP1272225A2 (en) 2003-01-08
DE60132184T2 (de) 2009-01-15
DK1272161T3 (da) 2008-05-19
EP1272161B1 (en) 2008-01-02
DE60122304D1 (de) 2006-09-28
EP1272160B1 (en) 2007-01-17
ES2295149T3 (es) 2008-04-16
EP1272225B1 (en) 2006-08-16
ES2280355T3 (es) 2007-09-16

Similar Documents

Publication Publication Date Title
DK1272225T3 (da) Lipidbaserede systemer til målrettet levering af diagnostiske midler
EA200601648A1 (ru) Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
DE60122335D1 (de) Zusammensetzung auf der basis polymerer mizellen
CR7901A (es) Pirazolilcarboxanilidas para la lucha contra los microorganismos indeseados
ATE345329T1 (de) Pyridinderivate als modulatoren des cb2-rezeptors
ATE501722T1 (de) Therapeutische behandlung androgenrezeptorbedingter leiden
UA83194C2 (ru) Производные пиримидина и их применение как модуляторов св2
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
AR047526A1 (es) Halogenoalquilcarboxamidas
ES2180274T3 (es) Disoluciones nasales.
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
DE60141636D1 (de) Phospholipidderivate von valproinsäure und ihre kombinationen
ECSP055965A (es) Oxatiincarboxamidas
TW200716616A (en) Modulators of CCR-5 activity
GT200000035AA (es) Derivados de resorcinol, (solicitud fraccionaria no. 1 derivada de la patente pi-2000-0035)
BR9911885A (pt) Inibidores da angiogênese
BR0009194A (pt) Composição do resorcinol
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
CR8073A (es) Iodopyrazolyl carboxanilidas
ITMI20031790A1 (it) Antagonistici abiotici dell'eparina.
MA34369B1 (fr) Agents anti-inflammatoires
DK1631298T3 (da) Glykosaminoglykaner til behandling af emotionelle funktionsforstyrrelser
DK1257538T3 (da) 9-alkylamino-1-nitroacridin-derivater